HB
Hera Biotech, Inc.
SEC filingBiotechnology · San Antonio, TX
Amount raised$1.7Msold at filing
Total offering$5M$3.3M still open
Investors in the raise26count reported to the SEC
FiledSep 23, 2026first sale Apr 11, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Wendy SmithDirector
Neal Walsdorf, Jr.Director
Teo TijerinaDirector
Somer BaburekExecutive Officer, Director
Paul CastellaDirector
Executive officers, directors and promoters as listed on the Form D.